2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses managing patients with prostate cancer under active surveillance.
Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses managing patients with prostate cancer under active surveillance.
Active surveillance is a positive option for many men with prostate cancer, as systemic treatment and radiation therapy have significant side effects.
When physicians are approaching the option of active surveillance with a patient, they must first help their patient cope with the diagnosis and then give necessary counseling, says Feldman.
Related Content: